Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2005-05-03
2005-05-03
Kemmerer, Elizabeth C (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C424S085100, C514S002600, C514S012200, C530S300000, C530S350000, C530S399000
Reexamination Certificate
active
06887477
ABSTRACT:
Preparations to be administered for treating or preventing ischemic diseases or arterial diseases which contain Hepatocyte growth factor (HGF) as an active ingredient. The preparations provide such effect that HGF concentration in an affected region to which HGF was administered is maintained, a half-life is longer, a dose can be reduced, and other organs except the affected region are less affected in comparison with intravenous administration.
REFERENCES:
patent: 5837676 (1998-11-01), Goldberg et al.
patent: 6133231 (2000-10-01), Ferrara et al.
patent: 6436388 (2002-08-01), Kudo et al.
patent: 6472366 (2002-10-01), Kishino et al.
patent: 6498144 (2002-12-01), Goldberg et al.
patent: A597694 (1993-04-01), None
patent: A6340546 (1994-12-01), None
patent: A7300426 (1995-11-01), None
patent: A8295634 (1996-11-01), None
patent: A1-9303061 (1993-02-01), None
Pettit et al. The development of site-specific drug-delivery systems for protein and peptide biopharmaceuticals. Trends in Biotech 16: 343-349, 1998.*
Pu et al. Enhanced revascularisation after angiogenic stimulation in a rabbit model of bilateral limb ischaemia. Eur J Vasc Endovasc Surg. 9(2):189-196, 1995.*
Pu et al. Angiogenic growth factor and revascularization of the ischemic limb: evaluation in a rabbit model. J Surg Res. 54(6):575-583, 1993.*
Uematsu Y et al. Effective administration route for the deleted form of hepatocyte growth factor To exert its pharmacological effects. J Pharm Sci. ;88(1):131-135, 1999.*
Takeshita et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit models of chronic limb ischemia. Circulation. 90:II228-234, 1994.*
Baffour et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant bFGF in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 16(2): 181-191, 1992.*
Taniyama et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Therapy 8: 181-189, 2001.*
Morishita et al. Therapeutic angiogensis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33: 1379-1384, 1999.*
Schaper et al. Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? Circulation 95: 2471-2472, 1997.*
Yamaguchi et al., Japanese Circulation Journal, vol. 62, Supp. I, p. 407 (1998).
Van Belle et al., Circulation, vol. 97, No. 4, pp. 381-390 (1998).
Kawamura Takao
Kudo Ikue
Maeda Hiroo
Nagano Tomokazu
Noguchi Hiroshi
Bunner Bridget E.
Kemmerer Elizabeth C
LandOfFree
Method of treating ischemic disease by intramuscular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating ischemic disease by intramuscular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating ischemic disease by intramuscular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3398255